AdAlta Limited Profile Avatar - Palmy Investing

AdAlta Limited

AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibr…

Biotechnology
AU, Melbourne [HQ]

Income Statements

Loading...
End of 1AD.AX's Analysis
CIK: - CUSIP: Q0101X107 ISIN: AU0000001AD2 LEI: - UEI: -
Secondary Listings
1AD.AX has no secondary listings inside our databases.